Akadeum and Agilent Team Up to Explore New Testing Workflow

Wednesday, October 30, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Novel Akadeum microbubble technology can be the answer to improved quality and reduced costs across multiple fields of testing.

ANN ARBOR, Mich., Oct. 30, 2019 /PRNewswire-PRWeb/ -- Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection.

Akadeum aims to disrupt the status quo in isolation technology with their buoyant microbubbles. Notably, Akadeum is the first company to commercialize buoyancy-based cell isolation with their growing portfolio of human and mouse cell enrichment kits for immunology researchers. In addition, the same technology can be leveraged to improve isolation workflows and capabilities for target molecules such as DNA, protein, microbes, and others, which Akadeum is developing through strategic partnerships.

"Sample preparation is a critical, yet often undervalued, step in most analytical assays. Often, the task of sample preparation employs decades old technology that is manual, time-consuming, and resource intensive," said Brandon McNaughton, CEO of Akadeum Life Sciences. "Akadeum was founded to bring simple and superior isolation solutions to a variety of industries through our buoyancy-based microbubble technology, and we are excited to be starting work with Agilent to explore new applications."

Agilent, an early investor in Akadeum, has engaged in this collaboration with the shared goal of using Akadeum microbubbles to improve upon current analytical workflows.

"The Akadeum technology has real promise to be a disruptive force in customers' sample preparation workflows. We're excited to test whether the simplicity of the solution drives down time and cost requirements in customer environments." said Michael Linderman, Vice President of Business Development at Agilent.

To learn more about Akadeum microbubbles, investment, or partnerships, visit https://www.akadeum.com.

Akadeum Life Sciences, Inc. was established to create the next generation isolation technology and to fundamentally change the way that isolating cells and other targets is approached. The company is using microbubbles to solve longstanding problems in the industry. Isolation applications include research, in vitro diagnostics, pathogen detection, and cell therapy. The company is located in Ann Arbor, MI. Inquiries into Akadeum's products or technology can be made at info@akadeum.com or https://www.akadeum.com/.

 

SOURCE Akadeum Life Sciences, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store